Asset Class
Equities Research Hub
Global equity markets are currently navigating a 'risk-off' environment characterized by a significant rotation from technology to defensive sectors. This shift is highlighted by a sharp 5.9% decline in the US Momentum factor and a correction in US tech stocks, even as companies like Alphabet continue massive investments in AI infrastructure. Earnings reports for 4Q25 reveal a mixed landscape; while consumer names like Yum! Brands show resilience, sector-specific pressures such as multiple compression for Ferrari and disappointing guidance from Information Services firm Gartner have led to price target downward revisions. In Europe, pharmaceutical giants GSK and Novartis have issued guidance trailing consensus, further contributing to a cautious outlook in the region. Regional equity sentiment is also being shaped by political developments, most notably in Japan, where a projected LDP victory is expected to support 'Abenomics'-style stimulus alongside Bank of Japan rate hikes totaling 75bp. Additionally, the cooling of Brent crude prices toward $68/b amid diplomatic progress in the Middle East and large-scale renewable energy investments, such as Saudi Arabia's $2bn solar agreement with Turkey, are influencing broader market dynamics. Despite localized volatility and currency fluctuations, global PMIs suggest an underlying 2.8% annualized rise in GDP, providing a macro cushion for diversified equity portfolios.
4204 reports available
All reports
Page 136 of 174
FX Weekly
MUFG · May 18, 2026
MS Capex Tracker: Stronger and Broader Exiting Q1 Earnings
Morgan Stanley · May 18, 2026
Middle East Daily
MUFG · May 18, 2026
FICC Focus: Trump/Bessent Northeast Asia Visit, US CPI, and IEA Oil Report
Mizuho Securities · May 18, 2026
Multi Asset Strategy Daily
Mizuho EMEA · May 18, 2026
Asia's Investment Super-Cycle and Competitive Reinvention
Morgan Stanley · May 18, 2026
First Take: FY26 Underlying EBIT In-Line With Expectations
Goldman Sachs · May 18, 2026
Utilities Daily: Datacenters in the UK and Europe at a Turning Point
Goldman Sachs · May 18, 2026
New Zealand Morning Focus
ANZ · May 18, 2026
FDA Management and Budget Cut Impact Analysis
ING · May 18, 2026
TMT Specialist Sales Update
Goldman Sachs · May 18, 2026
Insta360 CEO Product Demo and Innovation Strategy
Goldman Sachs · May 18, 2026
Archer Aviation In-Line 1Q26 Results
Goldman Sachs · May 18, 2026
Trading Catalysts Retail Earnings Wave NVDA and FOMC Minutes
Bank of America · May 18, 2026
European Contextual Diary
UBS · May 18, 2026
First Take: FY26 Trading Update - Revenue/EBIT Guide Lowered
Goldman Sachs · May 18, 2026
Silergy Corp Data Center and Auto Segments Set to Fuel Next Earnings Upcycle
Goldman Sachs · May 18, 2026
Huntington Ingalls Industries Management Meeting Takeaways
Goldman Sachs · May 18, 2026
Regeneron Pharmaceuticals Inc. (REGN): Ph3 Anti-LAG-3 Study In First-Line Metastatic Melanoma Fails
Goldman Sachs · May 18, 2026
Sonova Holdings FY26 Results Supported by Strong Momentum on Hearing Aids Wholesale Business
Goldman Sachs · May 18, 2026
Bank of Ireland Group: Updating Estimates Post Q1 2026 IMS
Goldman Sachs International · May 18, 2026
Power Semiconductors and Silicon Photonics with Node Migration at China Semis Panel
Goldman Sachs · May 18, 2026
Australian Morning Focus
ANZ · May 18, 2026
The Momentum Bubble Is Starting to Crack
The Market Ear · May 18, 2026